National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer

In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Langendijk, Johannes A., Hoebers, Frank J. P., de Jong, Martin A., Doornaert, Patricia, Terhaard, Chris H. J., Steenbakkers, Roel J. H. M., Hamming-Vrieze, Olga, van de Kamer, Jeroen B., Verbakel, Wilko F. A. R., Keskin-Cambay, Fatma, Reitsma, Johannes B., van der Schaaf, Arjen, Boersma, Liesbeth J., Schuit, Ewoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Particle Therapy Co-operative Group 2021
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270079/
https://www.ncbi.nlm.nih.gov/pubmed/34285961
http://dx.doi.org/10.14338/IJPT-20-00089.1
Descripción
Sumario:In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.

Ejemplares similares